COLOPLAST SP.ADR 1/10 DK1 Total Assets
COLOPLAST SP.ADR 1/10 DK1 total assets. Based on the latest financial reports, COLOPLAST SP.ADR 1/10 DK1 (CBH) holds total assets worth €48.80 Billion EUR (≈ $57.05 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see COLOPLAST SP.ADR 1/10 DK1 (CBH) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of COLOPLAST SP.ADR 1/10 DK1 (2021–2024)
Total assets of COLOPLAST SP.ADR 1/10 DK1 from 2021 to 2024. This chart illustrates how COLOPLAST SP.ADR 1/10 DK1's total assets have evolved over time, based on quarterly financial data. See COLOPLAST SP.ADR 1/10 DK1 share price for real-time trading data and today's change.
COLOPLAST SP.ADR 1/10 DK1 - Asset Composition Analysis
COLOPLAST SP.ADR 1/10 DK1 Total Assets Breakdown (September 2024)
COLOPLAST SP.ADR 1/10 DK1 total assets breakdown as of September 2024. COLOPLAST SP.ADR 1/10 DK1's total assets of €48.80 Billion consist of 21.7% current assets and 78.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 1.6% |
| Accounts Receivable | €4.67 Billion | 9.7% |
| Inventory | €3.67 Billion | 7.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €10.96 Billion | 22.8% |
| Goodwill | €19.38 Billion | 40.3% |
Asset Composition Trend (2021–2024)
This chart illustrates how COLOPLAST SP.ADR 1/10 DK1's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore COLOPLAST SP.ADR 1/10 DK1 (CBH) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: COLOPLAST SP.ADR 1/10 DK1's current assets represent 21.7% of total assets in 2024, a decrease from 44.2% in 2021.
- Cash Position: Cash and equivalents constituted 1.6% of total assets in 2024, down from 2.8% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 22.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 40.3% of total assets.
COLOPLAST SP.ADR 1/10 DK1 Competitors by Total Assets
Key competitors of COLOPLAST SP.ADR 1/10 DK1 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SARTORIUS (UNSP.ADS)/1/5
F:SRT0
|
Germany | €9.87 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
iRay Technology Co Ltd
SHG:688301
|
China | CN¥11.33 Billion |
|
Guangzhou Improve Med Instrument
SHE:300030
|
China | CN¥1.02 Billion |
|
Medeon Biodesign
TWO:6499
|
Taiwan | NT$1.55 Billion |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.39 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
COLOPLAST SP.ADR 1/10 DK1 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.30 | 0.81 | 1.02 |
| Quick Ratio | 0.81 | 0.52 | 0.66 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €2.37 Billion | €-2.40 Billion | €240.00 Million |
COLOPLAST SP.ADR 1/10 DK1 - Advanced Valuation Insights
This section examines the relationship between COLOPLAST SP.ADR 1/10 DK1's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.47 |
| Latest Market Cap to Assets Ratio | 0.26 |
| Asset Growth Rate (YoY) | -0.2% |
| Total Assets | €48.07 Billion |
| Market Capitalization | $12.73 Billion USD |
Valuation Analysis
Below Book Valuation: The market values COLOPLAST SP.ADR 1/10 DK1's assets below their book value (0.26x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: COLOPLAST SP.ADR 1/10 DK1's assets decreased by 0.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for COLOPLAST SP.ADR 1/10 DK1 (2021–2024)
The table below shows the annual total assets of COLOPLAST SP.ADR 1/10 DK1 from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-09-30 | €48.07 Billion ≈ $56.20 Billion |
-0.18% |
| 2023-09-30 | €48.16 Billion ≈ $56.30 Billion |
+28.61% |
| 2022-09-30 | €37.45 Billion ≈ $43.78 Billion |
+136.39% |
| 2021-09-30 | €15.84 Billion ≈ $18.52 Billion |
-- |
About COLOPLAST SP.ADR 1/10 DK1
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more